GARRET LAMENDOLA SITENGA MD
Prescription History 1891701736
Ophthalmology in Homer, AK


Quality Rating: 100 out of 100 score

NPI Status: Active since July 31, 2006

Contact Information

4381 E HILL RD
HOMER, AK
ZIP 99603
Phone: (907) 235-2358
Fax: (907) 235-9777

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for GARRET LAMENDOLA SITENGA MD, an active Ophthalmology specialist practicing in Homer, AK. Our medical registry currently tracks 13 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 1,699 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 538 claims alone.


Brimonidine Tartrate

Generic Formulation: Brimonidine TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 50
30-Day Fills 85.2
Days Supply 2,462
AK State Average Benchmarks
Peer Average Claims34.0
Peer Average 30-Day Fills61.3
Peer Average Days Supply1,784
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 47.1% more claims than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,193.54 across this reporting matrix range.

Provider Avg Cost Per Claim

$43.87

State Avg Cost Per Claim

$72.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Combigan

Generic Formulation: Brimonidine Tartrate/TimololSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 29
30-Day Fills 49.7
Days Supply 1,408
AK State Average Benchmarks
Peer Average Claims21.0
Peer Average 30-Day Fills41.0
Peer Average Days Supply1,188
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 38.1% more claims than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,998.27 across this reporting matrix range.

Provider Avg Cost Per Claim

$413.73

State Avg Cost Per Claim

$480.09

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Therapeutic Applications

This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details.

Dorzolamide Hcl

Generic Formulation: Dorzolamide HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 36
30-Day Fills 71.1
Days Supply 2,097
AK State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills57.9
Peer Average Days Supply1,721
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $913.61 across this reporting matrix range.

Provider Avg Cost Per Claim

$25.38

State Avg Cost Per Claim

$28.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors.

Dorzolamide-Timolol

Generic Formulation: Dorzolamide Hcl/Timolol MaleatSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 104
30-Day Fills 208.4
Days Supply 6,235
AK State Average Benchmarks
Peer Average Claims40.0
Peer Average 30-Day Fills77.1
Peer Average Days Supply2,302
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 160.0% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,356.42 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.66

State Avg Cost Per Claim

$33.92

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 12
30-Day Fills 16.5
Days Supply 495
AK State Average Benchmarks
Peer Average Claims19.0
Peer Average 30-Day Fills23.9
Peer Average Days Supply448
Conservative Utilization

This provider writes prescriptions for this formulation 36.8% less frequently than the standard regional baseline metric for practitioners inside AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $294.74 across this reporting matrix range.

Provider Avg Cost Per Claim

$24.56

State Avg Cost Per Claim

$35.31

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Latanoprost

Generic Formulation: LatanoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 538
30-Day Fills 794.8
Days Supply 21,444
AK State Average Benchmarks
Peer Average Claims53.0
Peer Average 30-Day Fills97.9
Peer Average Days Supply2,791
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 915.1% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $7,689.63 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.29

State Avg Cost Per Claim

$26.71

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

Therapeutic Applications

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

Lumigan

Generic Formulation: BimatoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 30
30-Day Fills 61.5
Days Supply 1,845
AK State Average Benchmarks
Peer Average Claims33.0
Peer Average 30-Day Fills71.7
Peer Average Days Supply2,108
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $16,128.97 across this reporting matrix range.

Provider Avg Cost Per Claim

$537.63

State Avg Cost Per Claim

$578.56

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Moxifloxacin

Generic Formulation: Moxifloxacin HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 134
30-Day Fills 134.0
Days Supply 2,372
AK State Average Benchmarks
Peer Average Claims39.0
Peer Average 30-Day Fills39.7
Peer Average Days Supply683
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 243.6% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,024.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$30.04

State Avg Cost Per Claim

$29.20

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.

Therapeutic Applications

This medication is a quinolone antibiotic used for eye infections.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 139
30-Day Fills 169.5
Days Supply 5,040
AK State Average Benchmarks
Peer Average Claims65.0
Peer Average 30-Day Fills86.2
Peer Average Days Supply2,247
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 113.8% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,218.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$66.32

State Avg Cost Per Claim

$56.75

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Timolol Maleate

Generic Formulation: Timolol MaleateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 253
30-Day Fills 465.8
Days Supply 13,430
AK State Average Benchmarks
Peer Average Claims35.0
Peer Average 30-Day Fills73.1
Peer Average Days Supply2,152
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 622.9% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,926.81 across this reporting matrix range.

Provider Avg Cost Per Claim

$15.52

State Avg Cost Per Claim

$31.05

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

Therapeutic Applications

This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers.

Tobramycin

Generic Formulation: TobramycinSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 21
30-Day Fills 22.2
Days Supply 592
AK State Average Benchmarks
Peer Average Claims12.0
Peer Average 30-Day Fills12.0
Peer Average Days Supply146
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 75.0% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $96.36 across this reporting matrix range.

Provider Avg Cost Per Claim

$4.59

State Avg Cost Per Claim

$586.08

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

An aminoglycoside, broad-spectrum antibiotic produced by Streptomyces tenebrarius. It is effective against gram-negative bacteria, especially the PSEUDOMONAS species. It is a 10% component of the antibiotic complex, NEBRAMYCIN, produced by the same species.

Therapeutic Applications

This medication is used to treat people with a certain inherited condition (cystic fibrosis) who have an ongoing lung infection with a certain bacteria (Pseudomonas aeruginosa). People with cystic fibrosis produce thick, sticky mucus that can plug up the tubes, ducts and passageways in the lungs. This can result in serious breathing problems and infections in the lungs. Tobramycin belongs to a class of drugs known as aminoglycoside antibiotics. Tobramycin inhalation solution works by stopping the growth of a certain bacteria (Pseudomonas aeruginosa) that commonly infects the lungs of people with cystic fibrosis. This effect decreases lung infections and damage, and helps to improve breathing.

Tobramycin-Dexamethasone

Generic Formulation: Tobramycin/DexamethasoneSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 188
30-Day Fills 205.4
Days Supply 4,915
AK State Average Benchmarks
Peer Average Claims48.0
Peer Average 30-Day Fills56.4
Peer Average Days Supply1,290
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 291.7% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $11,710.06 across this reporting matrix range.

Provider Avg Cost Per Claim

$62.29

State Avg Cost Per Claim

$82.79

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A topical preparation of tobramycin and dexamethasone that is used for treating or preventing superficial bacterial infections of the eye.

Therapeutic Applications

This medication is used to treat or prevent eye infections. This medication contains two drugs. Tobramycin belongs to a class of drugs called aminoglycoside antibiotics. It works by stopping the growth of bacteria. Dexamethasone belongs to a class of drugs called corticosteroids. It works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Travoprost

Generic Formulation: TravoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 165
30-Day Fills 235.5
Days Supply 6,213
AK State Average Benchmarks
Peer Average Claims25.0
Peer Average 30-Day Fills46.2
Peer Average Days Supply1,326
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 560.0% higher than the standard regional baseline profile for AK. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $27,552.28 across this reporting matrix range.

Provider Avg Cost Per Claim

$166.98

State Avg Cost Per Claim

$263.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like GARRET LAMENDOLA SITENGA MD provides transparency into local medical care patterns within Homer, AK.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Ophthalmology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.